(Q42904540)

10 November 2017

title

Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration (English)

1 reference

10 November 2017

1 reference

Tao Li

1

1 reference

10 November 2017

Ying Hou

2

1 reference

10 November 2017

Chun-xia Yan

3

1 reference

10 November 2017

Teng Chen

4

1 reference

10 November 2017

Yan Zhao

5

1 reference

10 November 2017

Sheng-bing Li

6

1 reference

10 November 2017

language of work or name

English

0 references

publication date

16 September 2010

1 reference

full work available at URL

10 November 2017

https://api.elsevier.com/content/article/PII:S0304394010012267?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

https://api.elsevier.com/content/article/PII:S0304394010012267?httpAccept=text/plain

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

15 July 2024

1 reference

10 November 2017

volume

485

1 reference

10 November 2017

issue

3

1 reference

10 November 2017

page(s)

256-260

1 reference

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

10 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

15 July 2024

Drug addiction

2

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

15 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D3 and D2 Dopamine Receptors

15 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization

15 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice

15 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A

15 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

15 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal

15 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors

15 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Role of dopamine D3 receptors in the addictive properties of ethanol.

15 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence

15 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Behavioral sensitization to intermittent morphine in mice is accompanied by reduced adrenocorticotropine but not corticosterone responses

15 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors

15 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Development of pharmacotherapies for drug addiction: a Rosetta stone approach

15 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The dopamine D3 receptor and drug dependence: effects on reward or beyond?

15 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade

15 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Addiction is a brain disease, and it matters

15 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

In vivo occupancy of D2 dopamine receptors by nafadotride

15 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion

15 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

15 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment

15 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion

15 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine

15 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

D3 dopamine receptor, behavioral sensitization, and psychosis

15 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents

15 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

15 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice

15 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

15 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

15 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors

15 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEULET.2010.09.025

15 July 2024

Identifiers

1 reference

10 November 2017

1 reference